- Home
- BHM vs OMIC Comparison
BHM vs OMIC Comparison
Compare BHM & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHM
- OMIC
- Stock Information
- Founded
- BHM 2022
- OMIC 2016
- Country
- BHM United States
- OMIC United States
- Employees
- BHM N/A
- OMIC N/A
- Industry
- BHM Real Estate Investment Trusts
- OMIC Medical/Dental Instruments
- Sector
- BHM Real Estate
- OMIC Health Care
- Exchange
- BHM Nasdaq
- OMIC Nasdaq
- Market Cap
- BHM 49.1M
- OMIC 50.4M
- IPO Year
- BHM N/A
- OMIC 2021
- Fundamental
- Price
- BHM $11.56
- OMIC $20.01
- Analyst Decision
- BHM
- OMIC Hold
- Analyst Count
- BHM 0
- OMIC 2
- Target Price
- BHM N/A
- OMIC $10.75
- AVG Volume (30 Days)
- BHM 3.6K
- OMIC 7.8K
- Earning Date
- BHM 01-01-0001
- OMIC 03-17-2025
- Dividend Yield
- BHM 2.16%
- OMIC N/A
- EPS Growth
- BHM N/A
- OMIC N/A
- EPS
- BHM N/A
- OMIC N/A
- Revenue
- BHM $58,198,000.00
- OMIC $2,667,000.00
- Revenue This Year
- BHM N/A
- OMIC $0.82
- Revenue Next Year
- BHM N/A
- OMIC $252.64
- P/E Ratio
- BHM N/A
- OMIC N/A
- Revenue Growth
- BHM 12.46
- OMIC 2.77
- 52 Week Low
- BHM $10.71
- OMIC $5.34
- 52 Week High
- BHM $19.01
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- BHM 38.95
- OMIC 56.74
- Support Level
- BHM $11.34
- OMIC $19.82
- Resistance Level
- BHM $11.76
- OMIC $20.27
- Average True Range (ATR)
- BHM 0.27
- OMIC 0.14
- MACD
- BHM 0.09
- OMIC 0.01
- Stochastic Oscillator
- BHM 70.04
- OMIC 44.68
About BHM Bluerock Homes Trust Inc.
Bluerock Homes Trust Inc owns and operates single-family properties that generate rental and other property-related income through the leasing of units to a diverse base of tenants. The properties are located in Sunbelt and the Western United States.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.